What Role Does Tobacco Smoking Play in Multiple Sclerosis Disability and Mortality? A Review of the Evidence
- 25 February 2015
- journal article
- review article
- Published by Taylor & Francis in Neurodegenerative Disease Management
- Vol. 5 (1) , 19-25
Abstract
There is increasing evidence of tobacco smoking as an associative factor in multiple sclerosis (MS). Numerous studies have been conducted investigating the effects of smoking before the onset of MS as well as its impact on disease course. This special report reviews the available evidence and summarizes the contribution of smoking to increased mortality in patients with MS. It also explores some putative mechanisms for the involvement of tobacco constituents in the pathology of MS and the effects of smoking on disease-modifying treatments.Keywords
This publication has 53 references indexed in Scilit:
- Cigarette smoking and associated risk of multiple sclerosis in the Iranian populationJournal of Clinical Neuroscience, 2013
- Incidence and prevalence of multiple sclerosis in the UK 1990-2010: a descriptive study in the General Practice Research DatabaseJournal of Neurology, Neurosurgery & Psychiatry, 2013
- Association of smoking with risk of multiple sclerosis: a population-based studyJournal of Neurology, 2013
- The association between cigarette smoking and multiple sclerosisJournal of the Neurological Sciences, 2011
- Alcohol, coffee, fish, smoking and disease progression in multiple sclerosisEuropean Journal of Neurology, 2011
- Smoking: effects on multiple sclerosis susceptibility and disease progressionTherapeutic Advances in Neurological Disorders, 2011
- Smoking and Increased Risk of Multiple Sclerosis: Parallel Trends in the Sex Ratio Reinforce the EvidenceAnnals of Epidemiology, 2011
- The changing demographic pattern of multiple sclerosis epidemiologyThe Lancet Neurology, 2010
- Multiple sclerosisThe Lancet, 2008
- Smoking is a risk factor for early conversion to clinically definite multiple sclerosisMultiple Sclerosis Journal, 2008